Making HIV care decisions with people who've been in the justice system
Part of Mental health clinical trials.
This trial helps people recently involved with the justice system and who use stimulants or opioids decide on HIV prevention or treatment. It tests a shared decision-making approach for taking HIV medication (ART) or PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can give consent in English or Spanish.
- You live in Western Connecticut, Dallas or Tarrant counties in Texas, or Madison County in Kentucky.
- You've been in jail, prison, or on community supervision in the last 12 months.
- You're willing to get an HIV test.
- If you have HIV, you haven't taken HIV meds (ART) in the past 6 months. If you don't have HIV, you haven't taken PrEP in the past 12 months but need it (due to condomless sex, sharing injection equipment, or a recent bacterial STI).
- You've used opioids or stimulants in the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This study tests a counseling program to help women decide whether to use PrEP (a daily pill that prevents HIV). It aims to make PrEP choices easier and more informed in sexual and reproductive health clinics.
This study helps young adults who have had contact with the criminal legal system access HIV prevention services and support for substance use. Researchers will connect you with health resources and track whether an app-based service helps you stay healthy and engaged with care.
This study tests an integrated phone-based health program (e-health) designed for women involved with the justice system who have opioid use disorder. It aims to help people who qualify for HIV prevention (PrEP) stay protected, especially by using simple, ongoing support through phone access.
This study tests whether a combination of buprenorphine (a medication for opioid addiction) and PrEP (a daily pill to prevent HIV) can help people who are leaving jail or prison stay healthy. It aims to reduce both opioid relapse and HIV risk during the transition back to the community.
This study helps Black men who have sex with men or other key populations who have been involved with the justice system get HIV services and job support. It aims to connect you to care and employment help, especially if you aren't already receiving HIV or PrEP care.
Hear when a new Substance Use Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.